CI
STML

Cowen Inc’s Stemline Therapeutics, Inc. STML Stock Holding History

Cowen Inc’s Portfolio STML Stock Details STML Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-22,700
Closed -$364 – 666
2018
Q2 		$364 Buy
+22,700
New +$405K 0.02% 291
2018
Q1 		– Sell
-23,950
Closed -$374K – 313
2017
Q4 		$374K Sell
23,950
-13,850
-37% -$185K ﹤0.01% 214
2017
Q3 		$420K Buy
+37,800
New +$355K 0.01% 176
2017
Q2 		– Sell
-76,900
Closed -$657K – 364
2017
Q1 		$657K Buy
+76,900
New +$701K 0.03% 154

Other funds holding STML

CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
PC
Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LSC
Lyon Street Capital Sausalito, California $67M AUM
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Cowen Inc's STML Position: Q3 2018 in Review

Cowen Inc sold out of Stemline Therapeutics, Inc. (STML) in Q3 2018, closing a stake of 22,700 shares — an estimated $364 sold.

Cowen Inc first reported a position in STML in Q1 2017 and held it in 4 quarters. The position peaked at $657K in Q1 2017. 90 funds tracked by Wall St. Rank hold STML as of Q3 2018.

  • Cowen Inc reported no remaining Stemline Therapeutics, Inc. position as of Q3 2018 after selling out during the quarter.
  • Cowen Inc sold 22,700 Stemline Therapeutics, Inc. shares in Q3 2018, an estimated $364.
  • Cowen Inc first reported a position in Stemline Therapeutics, Inc. in Q1 2017 and held it in 4 quarters.
  • Cowen Inc's Stemline Therapeutics, Inc. position peaked at $657K in Q1 2017.
  • 90 funds tracked by Wall St. Rank held Stemline Therapeutics, Inc. as of Q3 2018.

Based on Cowen Inc's 13F filing for Q3 2018, filed 13 Nov 2018.